Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Loss of TET2 increases the risk of skin and oral cancer.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Cepharanthine shows promise as a natural anticancer treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The compound 4c showed strong potential as an anticancer agent.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Nilotinib can cause generalized keratosis pilaris.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

JAK inhibitors are effective for long-term management of alopecia areata.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Blocking DKK1 with siRNA can improve hair growth.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.